NEW YORK (360Dx) — Japanese drugmaker Daiichi Sankyo announced today that it has partnered with Roche to develop an immunohistochemistry-based companion diagnostic for one of its investigational breast cancer drugs.
NEW YORK (360Dx) — Japanese drugmaker Daiichi Sankyo announced today that it has partnered with Roche to develop an immunohistochemistry-based companion diagnostic for one of its investigational breast cancer drugs.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.
Don't have a 360Dx or GenomeWeb account?
Register for Free.